Alembic Pharma

APLLTD18 May 2024
Pharmaceuticals
+7.85 (+0.82%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Alembic Pharma
Alembic Pharma
Pharmaceuticals
APLLTD18 May 2024
+7.85 (+0.82%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Alembic Pharma - Share Price & Details

Lowest Today
951
Highest Today
989.95
Today’s Open
965.9
Prev. Close
959.9
52 Week High
1094
52 Week Low
542.4
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
73.01%
Upper Circuit
Lower Circuit
P/E TTM
28.51
P/B Ratio
3.87
Traded Value(Cr)
0.00
EPS TTM
33.91
Book value
Dividend
1.14%

Price Performance

1.52 %
1 Wk
3.94 %
1 M
-3.63 %
3 M
73.01 %
1 Y
26.35 %
YTD

Traded Volume Movement

Technical Details

Support 3
911
Support 2
931
Support 1
950
Pivot Point :
970
Resistance 1
989
Resistance 2
1009
Resistance 3
1028

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Alembic Pharmaceuticals Ltd
₹967.75(+7.85/0.82%)
967.75+7.8519,022.4073.0128.513.87
Lupin Ltd
₹1,660.30(+8.55/0.52%)
1,660.30+8.5575,668.19113.0532.523.67
Ipca Laboratories Ltd
₹1,309.75(+8.05/0.62%)
1,309.75+8.0533,228.9193.9960.415.36
J B Chemicals & Pharmaceuticals Ltd
₹1,843.00(+18.00/0.99%)
1,843.00+18.0028,602.4083.6856.4310.65
Sanofi India Ltd
₹8,869.25(+17.30/0.20%)
8,869.25+17.3020,425.8838.6935.8220.02
376.25+2.252,208.79-12.9516.341.37

About Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 19000.77 crores. It has reported a sales of Rs. 1474.55 crores and a net profit of Rs. 201.87 crores for the quarter ended December 2018. The company management includes Chirayu R Amin, Chirayu R Amin,Pranav N Parikh,K G Ramanathan,Paresh Saraiya,Rajkumar Baheti,Pranav Amin,Shaunak Amin,Archana Hingorani,Ashok Barat,Manisha Saraf,Jai S Diwanji (Alembic Pharmaceuticals Ltd) among others.
Chairman
Chirayu R Amin
Registered office
Alembic Road,,Vadodara,Gujarat,390003
FAX :91-0265-2282506
Background
Incorporation Year2010
Face Value₹2
Market Lot1

Latest News

Trade setup for Tuesday: 15 things to know before opening bell
Before market opens on Tue, check these things:
📌Key Levels For The Nifty 50
📌Key Levels For The Bank Nifty
📌Nifty Call Options Data
📌Nifty Put Options Data
📌Bank Nifty Call Options Data
📌Bank Nifty Put Options Data
📌Put-Call Ratio
📌India VIX
📌Long Unwinding (31 Stocks)
📌 Short Build-up (30 Stocks)
📌Short-Covering (57 Stocks)
📌 High Delivery Trades
📌Stocks Under F&O Ban
20 May 2024 | 07:29 PM
Trade setup for Tuesday: 15 things to know before opening bell
Before market opens on Tue, check these things:
📌Key Levels For The Nifty 50
📌Key Levels For The Bank Nifty
📌Nifty Call Options Data
📌Nifty Put Options Data
📌Bank Nifty Call Options Data
📌Bank Nifty Put Options Data
📌Put-Call Ratio
📌India VIX
📌Long Unwinding (31 Stocks)
📌 Short Build-up (30 Stocks)
📌Short-Covering (57 Stocks)
📌High Delivery Trades
📌Stocks Under F&O Ban.
20 May 2024 | 07:29 PM
IRIS Business S Consolidated March 2024 Net Sales at Rs 30.35 crore
Reported Consolidated quarterly numbers for IRIS Business Services are:Net Sales at Rs 30.35 crore in March 2024 up 47.66% from Rs. 20.56 crore in March 2023.Quarterly Net Profit at Rs. 4.71 crore in March 2024 up 197.45% from Rs. 1.58 crore in March 2023.EBITDA stands at Rs. 6.66 crore in March 2024 up 96.46% from Rs. 3.39 crore in March 2023.
20 May 2024 | 11:55 PM
JB Pharma aims 12-14% revenue growth over next 2 years: CEO
JB Pharma, majority-owned by investment firm KKR & Co., aims to grow its revenue by 12-14% in the next couple of years with a thrust on domestic and contract development and manufacturing organization (CDMO) businesses, its chief executive Nikhil Chopra said. The company is also foraying into new geographies like Europe and Brazil through tie-ups and product launches.
20 May 2024 | 08:17 PM
Hindustan Aeronautics Consolidated March 2024 Net Sales at Rs 14,768.75 cr
Reported Consolidated quarterly numbers for Hindustan Aeronautics are: Net Sales at Rs 14,768.75 crore in March 2024 up 18.2% from Rs. 12,494.67 crore in March 2023.Quarterly Net Profit at Rs. 4,308.71 crore in March 2024 up 52.19% from Rs. 2,831.18 crore in March 2023. EBITDA stands at Rs. 6,458.57 crore in March 2024 up 62.77% from Rs. 3,968.02 crore in March 2023.
20 May 2024 | 08:02 PM

How to buy Alembic Pharma shares on nse?

To buy Alembic Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Alembic Pharma share price today?

The Alembic Pharma shares price on nse is Rs.967.75 today.

What is the market cap of Alembic Pharma shares on NSE ?

The company has a market capitalization of Rs.19022.40Cr

What is the PE & PB ratio of Alembic Pharma shares ?

PE is 28.51 and PB is 3.87

What is the 52 Week High and Low of Alembic Pharma shares?

Alembic Pharma stock price high: Rs.1094 Alembic Pharma stock price low: Rs.542.4

How can I purchase stock in Alembic Pharma?

You can use the services of a reliable broker like Motilal Oswal to purchase stock in Alembic Pharma. All you have to do is sign up with the broker and open demat and trading accounts. You can buy stocks in Alembic Pharma on the stock exchange through the broker. 

 

Is Alembic Pharma a good investment?

According to some analysts, Alembic Pharma is an undervalued stock at present. Still, it may be a good investment if you are thinking of a long-term view as the stock may see an upside in the future. 

Is Alembic Pharma debt-free?

In September 2022, Alembic Pharma held debt at approximately Rs. 7.71 billion, down from the previous year. 

What is the dividend yield of Alembic Pharma?

The dividend yield of Alembic Pharma is 2.09% (March 2022).